Phone
Send Email
whatsapp
Facebook
Youtube
Thyroid-Stimulating Hormone (TSH) Immunofluorescence Assay: Comprehensive Thyroid Health Management with Integrated FT4/FT3 Testing
2025-04-28
TSH-FT4-FT3: The Golden Triad for Thyroid Function AssessmentThyroid-Stimulating Hormone (TSH), the central regulator of the pituitary-thyroid axis, serves as the "first signal" for thyroid dysfunction. Free Thyroxine (FT4) and Free Triiodothyronine (FT3), whi...
view detail 
Protect the starting point of life: check before pregnancy, build the first line of defense for maternal love
2025-03-21
An estimated 303000 women worldwide died from pregnancy-related causes each year. More than 8 million babiesworldwide are born with a seriousbirth defect each year. Receiving appropriate testing and care can reduce the risk of death from pregnancy-related...
view detail 
Medlab Middle East 2025: A Vital Hub for Medical Innovation and Collaboration, Dubai, UAE
2024-12-30
MEDLAB MIDDLE EAST 2025 will be held at the Dubai World Trade Center from February 3-6, 2025, bringing together leading global medical laboratory companies and brands to provide professionals with a platform for on-site communication, exchange, and trade. ...
view detail 
Great News! Aehealth Products NGSP Certified Again!
2024-12-13
Aehealth Limited proudly announces that its Lamuno series immunofluorescence analyzer has successfully participated in the National Glycohemoglobin Standardization Program (NGSP) and received certification. This achievement confirms the reliable performance of the Lamuno equipment in the quantitative detection of glycated hemoglobin, ensuring consistency across various laboratories. As a result, Aehealth's glycated hemoglobin analysis and testing platform demonstrates international standardization and quality assurance. This milestone underscores the company's commitment to enhancing its quality improvement processes, reinforcing its position in the global healthcare market. Aehealth continues to advance the reliability and accuracy of its diagnostic tools, further establishing itself as a leader in medical technology
World Diabetes Day: Advocating for Awareness and Prevention
2024-11-14
World Diabetes Day 2024 November 14, 2024 is the 18th United Nations Diabetes Day (WDD). WDD is led by the International Diabetes Federation (IDF) and each World Diabetes Day focuses on a theme related to diabetes. Type 2 diabetes is a largely preventable and...
view detail 
High-sensitivity cardiac troponin I (Hs-cTnI): a new marker of heart health
2024-11-07
In recent years, cardiovascular disease has become a major health concern worldwide. With advancements in medical technology, early detection and monitoring of heart disease have become increasingly important. In this regard, high-sensitivity cardiac troponin...
view detail 
Study Reveals Vitamin B12's Health Impact
2024-09-23
AEHEALTH LIMITED has reported on the importance of vitamin B12 in maintaining overall health. The company highlighted the potential risks of vitamin B12 deficiency, which can affect the nervous system and lead to fatigue, weakness, and anemia. AEHEALTH LIMITED emphasized the need for individuals to be aware of their vitamin B12 levels and to consume sources of the vitamin such as meat, fish, and dairy products. The company also emphasized the importance of regular check-ups and consulting with healthcare professionals to monitor and address any potential deficiencies. This news comes as a reminder for people to prioritize their vitamin intake for their overall health and well-being
view detail 
Laffinite II Achieves NGSP Certification
2024-06-05
AEHEALTH LIMITED announced that its Laffinite II HbA1c method has received certification from the NGSP, signifying a major advancement in medical diagnostics. The certification solidifies the Laffinite II analyzer as a state-of-the-art solution for automated isolation of HbA1c. This achievement is a significant milestone for the company and underscores the superior quality and reliability of its diagnostic technology. The groundbreaking development has the potential to greatly impact the medical field and improve patient care. AEHEALTH LIMITED's commitment to innovation and excellence has been recognized through this certification, positioning the company as a leader in advanced medical diagnostics
view detail 
New study reveals four crucial tests for rheumatic diseases
2024-06-01
Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects the joints, causing pain, swelling, stiffness, and loss of function. It can also affect other organs. The World Health Organization (WHO) estimates that approximately 1% of the world’s population is affected by RA, with women being three times more affected than men. The disease can occur at any age, but most commonly occurs after age 40 and before age 60. If not properly controlled, rheumatoid arthritis can cause severe disability and shorten life expectancy.